Our Team

A strong committed leadership focused on advancing the future of pain management

Galit Zuckerman Stark

Founder, CEO and board member

Ms. Zuckerman Stark brings to Medasense over twenty years of entrepreneurship, management and engineering experience in both start-ups and large corporations. Ms. Zuckerman Stark founded Medasense upon discovering that while advanced algorithms are used frequently in many different industries such as semiconductors, communication, and many others, the discipline of medicine and specifically pain was still left behind....

Before founding Medasense she led algorithm teams at Applied Materials and worked at Nokia-Siemens and Nice Systems. Ms. Zuckerman started her technology career at the elite Israeli Defense Forces “Haman Talpiot” program. She also served as a consultant for several start-up companies in the field of signal and image processing including BoneTone Communications which was successfully acquired by DSPG Inc in 2011.

Ms. Zuckerman Stark holds an MSc degree in Electrical Engineering (cum laude, Engineering Faculty Excellence Program) and a BSc in Computer Engineering (cum laude, Adi Lautman special program for outstanding students TAU) from Tel Aviv University, Israel.

Walter Tabachnik

CFO

Mr. Tabachnik served as the Executive Vice President and Chief Financial Officer of Oridion Systems, a successful patient monitoring company. He led their successful acquisition by the global healthcare company, Covidien, for $346M in 2012. Mr. Tabachnik later served as Covidien’s Director of Strategy and Portfolio EMEA....

Previously Mr. Tabachnik has held a number of senior accounting positions in various distinguished firms in Israel and South Africa. Mr. Tabachnik is a Certified Public Accountant in Israel and holds a BA in Accounting and Economics from the Hebrew University of Jerusalem, Israel.

Rachel Weissbrod

VP Clinical, Regulatory and QA Affairs

Ms. Weissbrod brings twenty years of experience in the medical device industry in clinical strategy and market development, regulatory affairs and quality assurance, product innovation and management. Prior to joining Medasense, Ms. Weissbrod was a Global Director of Medical Affairs & Value Based Healthcare at Medtronic focusing on clinical market development for patient monitoring devices....

Ms. Weissbrod has held leadership roles in Quality Assurance, Regulatory & Clinical Affairs at Covidien, Oridion Medical and additional start-up companies with extensive experience in leading teams in the development and execution of global regulatory, quality and clinical strategies supporting new product development and commercialization.

Ms. Weissbrod holds a B.Pharm, and an MBA, both from the Hebrew University, Jerusalem, Israel.

Enrique Linaza

VP GLOBAL SALES

Mr. Linaza brings over fifteen years of medical device business development experience. Prior to joining Medasense, Mr Linaza led business development in Iberia at Oticon Medical (Demant group) as well as other roles including Sales Director Eastern Europe & Asia focused on cochlear implant hearing solutions. Throughout his career, Mr. Linaza has worked for big global structures and with local distributors gaining experience in growing both new and mature businesses at different stages of the product life cycle in both public and private health systems. Mr. Linaza couples hands-on clinical knowledge with commercial strategy, leading teams to achieve commercial success.

Mr. Linaza holds an Executive MBA from the IE Business School, an MSc from UCAM University and a physiotherapy degree from CEU University.

Ofir Gur

VP R&D

As a versatile and experienced R&D professional, Mr. Gur has a passion for innovation and a proven track record of success in managing and delivering complex projects in key roles across a variety of organizations. His expertise encompasses a wide range of technologies, from cloud-based systems to low-level embedded projects.

Before Medasense, Ofir lead a team in the Technology Research & Innovation group at Perion and later was a part of the CTO office leading adoptions of new technologies (NASDAQ: PERI).

He is skilled at building and leading high-performing teams, coordinating complex tasks and activities, and driving results in challenging, ever-changing environments.